Latest Advances

  • Journal: European review for medical and pharmacological sciences
  • Published —
Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study.
  • Condition: Sintilimab-Induced Diabetic Ketoacidosis (DKA) in Patient with Small Cell Lung Cancer
  • Journal: Medicine
  • Treatment Used: Insulin Therapy, Sintilimab Discontinuation and Conversion to Durvalumab
  • Number of Patients: 1
  • Published —
This case report describes a 59-year-old man with small cell lung cancer diagnosed with sintilimab-induced diabetic ketoacidosis treated with insulin therapy, sintilimab discontinuation and conversion to durvalumab.
  • Journal: Orphanet journal of rare diseases
  • Published —
Lymphoproliferative malignancies in patients with neurofibromatosis 1.
  • Condition: Hodgkin's Lymphoma (HL)
  • Journal: Upsala journal of medical sciences
  • Treatment Used: Radiotherapy
  • Number of Patients: 0
  • Published —
This study initiated an intervention study to decrease morbidity and mortality of cardiovascular disease (CVD) in patients with Hodgkin's lymphoma (HL).
  • Condition: Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Brentuximab Vedotin (BV) after Autologous Stem Cell Transplantation (ASCT)
  • Number of Patients: 383
  • Published —
This study examined the overall survival (OS) and progression-free survival (PFS) in patients with relapsed (recurring) or refractory (resistant to treatment) classical Hodgkin lymphoma (a cancer of the lymphatic system; cHL) treated with brentuximab vedotin (BV) after autologous stem cell transplantation (stem cells are removed from a person, stored, and later given back to that same person; ASCT).
Showing 1-12 of 147